These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 32990054

  • 1. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety.
    Potter N, Panay N.
    Climacteric; 2021 Feb; 24(1):19-24. PubMed ID: 32990054
    [Abstract] [Full Text] [Related]

  • 2. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
    Edwards D, Panay N.
    Climacteric; 2016 Apr; 19(2):151-61. PubMed ID: 26707589
    [Abstract] [Full Text] [Related]

  • 3. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview.
    Sinha A, Ewies AA.
    Climacteric; 2013 Jun; 16(3):305-12. PubMed ID: 23215675
    [Abstract] [Full Text] [Related]

  • 4. Assessment of ospemifene or lubricants on clinical signs of VVA.
    Constantine G, Graham S, Koltun WD, Kingsberg SA.
    J Sex Med; 2014 Apr; 11(4):1033-1041. PubMed ID: 24443923
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
    Labrie F, Archer DF, Koltun W, Vachon A, Young D, Frenette L, Portman D, Montesino M, Côté I, Parent J, Lavoie L, BSc AB, Martel C, Vaillancourt M, Balser J, Moyneur É, members of the VVA Prasterone Research Group.
    Menopause; 2018 Nov; 25(11):1339-1353. PubMed ID: 30358731
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
    Labrie F, Archer DF, Koltun W, Vachon A, Young D, Frenette L, Portman D, Montesino M, Côté I, Parent J, Lavoie L, Beauregard A, Martel C, Vaillancourt M, Balser J, Moyneur É, VVA Prasterone Research Group.
    Menopause; 2016 Mar; 23(3):243-56. PubMed ID: 26731686
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of the genitourinary syndrome of menopause.
    Palacios S, Mejía A, Neyro JL.
    Climacteric; 2015 Mar; 18 Suppl 1():23-9. PubMed ID: 26366797
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genitourinary Syndrome of Menopause.
    Shifren JL.
    Clin Obstet Gynecol; 2018 Sep; 61(3):508-516. PubMed ID: 29787390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.